Literature DB >> 9892327

Congestive heart failure in the community: trends in incidence and survival in a 10-year period.

M Senni1, C M Tribouilloy, R J Rodeheffer, S J Jacobsen, J M Evans, K R Bailey, M M Redfield.   

Abstract

OBJECTIVE: To compare the incidence of congestive heart failure and the survival in patients with congestive heart failure in Rochester, Minn, in 1981 with that observed in 1991.
METHODS: Population-based, descriptive epidemiological study with ecological and individual level comparisons over time. Olmsted County, Minnesota, where the Rochester Epidemiology Project provides passive surveillance of the population for health outcomes. All 248 patients fulfilled the Framingham criteria, 107 patients presenting with the new onset of congestive heart failure in 1981 and 141 patients in 1991. The community inpatient and outpatient medical records of all incident cases were reviewed to evaluate the presenting characteristics of patients at diagnosis.
RESULTS: The incidence of congestive heart failure after adjustment for age and sex to the US population was not significantly different in the 1991 cohort compared with that in 1981 (3.0 per 1000 person-years; 95% confidence interval, 2.5-3.5 vs 2.8 per 1000 person-years; 95% confidence interval, 2.2-3.3; P = .55). The survival of patients with new diagnosis of congestive heart failure was similar in the 2 cohorts (P = .53). Survival adjusted for age, sex, and New York Heart Association functional class was not significantly different in patients with congestive heart failure in 1981 and 1991 (relative risk, 0.907; P = .55).
CONCLUSIONS: These data suggest that recent advances in management of cardiovascular disease, as used in the community, had not yet impacted incidence or survival of patients with congestive heart failure in the community during the 10-year study period. This highlights the need to continue efforts to ensure that advances in diagnosis and therapy are incorporated into the care of patients with congestive heart failure in the community.

Entities:  

Mesh:

Year:  1999        PMID: 9892327     DOI: 10.1001/archinte.159.1.29

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  55 in total

1.  Left ventricular hypertrophy: unresolved issues.

Authors:  J A Schoenberger
Journal:  Curr Hypertens Rep       Date:  1999-08       Impact factor: 5.369

2.  Limitations of the use of clinical trial results in managing heart failure in the African-American community: a time for active participation in generating applicable data.

Authors:  Joseph A Franciosa
Journal:  J Natl Med Assoc       Date:  2003-01       Impact factor: 1.798

3.  In-hospital management of heart failure: in 10 years we have improved, but not enough.

Authors:  Sonia Ferretto; Chiara Dalla Valle; Sonia Cukon Buttignoni; Luca Brugnaro; Giovanni Maria Boffa
Journal:  Intern Emerg Med       Date:  2010-12-09       Impact factor: 3.397

4.  A systematic assessment of causes of death after heart failure onset in the community: impact of age at death, time period, and left ventricular systolic dysfunction.

Authors:  Douglas S Lee; Philimon Gona; Irene Albano; Martin G Larson; Emelia J Benjamin; Daniel Levy; William B Kannel; Ramachandran S Vasan
Journal:  Circ Heart Fail       Date:  2010-11-11       Impact factor: 8.790

Review 5.  Gender and heart failure: a population perspective.

Authors:  P A Mehta; M R Cowie
Journal:  Heart       Date:  2006-05       Impact factor: 5.994

6.  A history of arterial hypertension does not affect mortality in patients hospitalised with congestive heart failure.

Authors:  F Gustafsson; C Torp-Pedersen; M Seibaek; H Burchardt; O Wendelboe Nielsen; L Køber
Journal:  Heart       Date:  2006-04-18       Impact factor: 5.994

7.  Utility of Framingham risk score in urban emergency department patients with asymptomatic hypertension.

Authors:  Aaron M Brody; John M Flack; Brian A Ference; Phillip D Levy
Journal:  Crit Pathw Cardiol       Date:  2014-09

8.  Consultation with cardiologists for persons with new-onset chronic heart failure: a population-based study.

Authors:  Debbie Ehrmann Feldman; Yongling Xiao; Sasha Bernatsky; Jeannie Haggerty; Karen Leffondré; Pierre Tousignant; Yves Roy; Michael Abrahamowicz
Journal:  Can J Cardiol       Date:  2009-12       Impact factor: 5.223

Review 9.  Comorbidity of atrial fibrillation and heart failure.

Authors:  Liang-Han Ling; Peter M Kistler; Jonathan M Kalman; Richard J Schilling; Ross J Hunter
Journal:  Nat Rev Cardiol       Date:  2015-12-10       Impact factor: 32.419

Review 10.  The heart failure epidemic.

Authors:  Véronique L Roger
Journal:  Int J Environ Res Public Health       Date:  2010-04-19       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.